In his new position as US Account Manager, Russell Katz takes over the operational and strategic responsibility for sales and service in North America and Canada. Mr. Katz has been working in the American biotechnology industry for many years and most recently held the position of Sales Manager of Eppendorf in the States.
Dr. Frank Kensy, Managing Director of m2p-labs, comments: "I am delighted to announce the appointment of Russ which demonstrates the strategic importance of the North America market as one of the key markets for m2p-labs. As experienced sales person with a background in biotechnology he has an excellent knowledge of the market and has already worked with a number of biotech companies."
"m2p-labs is a highly innovative biotechnology company offering screening systems for an efficient development of bioprocesses. With its unique technology microbial cells can be screened and controlled on micro scale and highly parallel." Mr. Katz explains.
For nearly ten years the company operates successfully in the European Life Science market and currently expands its leading technology position in the international markets. The subsidiary m2p-labs, Inc. was established in the US in January 2012 in order to be closer to its US clients. Mr. Katz will now be able to provide US customers with more efficient sales and service and to develop the market more effectively.
Dr. Frank Kensy, Managing Director of m2p-labs, comments: "I am delighted to announce the appointment of Russ which demonstrates the strategic importance of the North America market as one of the key markets for m2p-labs. As experienced sales person with a background in biotechnology he has an excellent knowledge of the market and has already worked with a number of biotech companies."
"m2p-labs is a highly innovative biotechnology company offering screening systems for an efficient development of bioprocesses. With its unique technology microbial cells can be screened and controlled on micro scale and highly parallel." Mr. Katz explains.
For nearly ten years the company operates successfully in the European Life Science market and currently expands its leading technology position in the international markets. The subsidiary m2p-labs, Inc. was established in the US in January 2012 in order to be closer to its US clients. Mr. Katz will now be able to provide US customers with more efficient sales and service and to develop the market more effectively.
